Boehringer Ingelheim Venture Fund
0 followers
About Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund is the corporate venture arm of Boehringer Ingelheim, investing in pioneering science to redefine the standard of care and bring new medicines to patients. The fund focuses on first-in-class, disease-modifying therapeutics across multiple modalities and supports early-stage biotech companies. It maintains a global presence with active engagement in Europe, the United States, and China, and has built a portfolio of numerous biotech ventures to drive pharmaceutical innovation.